Global Cyclooxygenase2 inhibitor Market Size study, by Indication (Osteoarthritis, Rheumatoid arthritis and Others), Types (Selective cox 2 inhibitor and Non-selective cox 2 inhibitor), Route of Administration (Oral, parenteral and Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecasts 2020-2026

  • Product Code:
    RP-ID-10324805
  • Published Date:
    19 Jun 2020
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global Cyclooxygenase2 inhibitor Market is valued approximately USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. Cyclooxygenase2 inhibitor also known as COX-2 inhibitor, is a nonsteroidal anti-inflammatory drug used to relieve pain and inflammation. Cyclooxygenase-2 inhibitors are being studied in the prevention of colon polyps, and as anticancer drugs. Factors such as rising awareness of the condition, high acceptance rate of cox 2 inhibitors, such as painkillers, are responsible for the development of the global market for cyclooxygenase 2 inhibitors. In addition, the growing prevalence of chronic diseases such as rheumatoid arthritis may also fuel this demand development. For instance, rheumatoid arthritis is a chronic disease affecting over 1.3 million Americans and as much as 1% of the worldwide population in 2018. However, safety issues and severe side effects of cox 2 inhibitors can restrain the growth of this market.

The regional analysis of Coronavirus Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Due to increasing awareness of chronic disease diagnosis and high prevalence, Asia-Pacific is projected to account for the largest market share for cyclooxygenase 2 inhibitor market in the coming years. Europe is considered to hold promising opportunities for development in the coming years, while North America is considered to lead the rise due to global players' focus on emerging technologies.

Major market player included in this report are:
Pfizer Inc.
Bayer AG
Novartis AG
Sabinsa
Cadila Pharmaceuticals
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Alembic Pharmaceuticals Limited
Aurobindo Pharma
Cipla Inc.
Torrent Pharmaceuticals Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Osteoarthritis
Rheumatoid arthritis
Others
By Type:
Selective cox 2 inhibitor
Non-selective cox 2 inhibitor
By Route of Administration:
Oral
Parenteral
Others
By End-Users:
Hospitals
Specialty Clinics
Others
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the Global Cyclooxygenase2 inhibitor Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Global Cyclooxygenase2 inhibitor Market, by Region, 2018-2026 (USD Billion)
1.2.2. Global Cyclooxygenase2 inhibitor Market, by Indication, 2018-2026 (USD Billion)
1.2.3. Global Cyclooxygenase2 inhibitor Market, by Route of Administration, 2018-2026 (USD Billion)
1.2.4. Global Cyclooxygenase2 inhibitor Market, by End-Users, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cyclooxygenase2 inhibitor Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cyclooxygenase2 inhibitor Market Dynamics
3.1. Global Cyclooxygenase2 inhibitor Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Cyclooxygenase2 inhibitor Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cyclooxygenase2 inhibitor Market, by Indication
5.1. Market Snapshot
5.2. Global Cyclooxygenase2 inhibitor Market by Indication, Performance - Potential Analysis
5.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Indication 2016-2026 (USD Billion)
5.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
5.4.1. Osteoarthritis
5.4.2. Rheumatoid arthritis
5.4.3. Others
Chapter 6. Global Cyclooxygenase2 inhibitor Market, by Type
6.1. Market Snapshot
6.2. Global Cyclooxygenase2 inhibitor Market by Type, Performance - Potential Analysis
6.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
6.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
6.4.1. Selective cox 2 inhibitor
6.4.2. Non-selective cox 2 inhibitor
Chapter 7. Global Cyclooxygenase2 inhibitor Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Cyclooxygenase2 inhibitor Market by Route of Administration, Performance - Potential Analysis
7.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Route of Administration 2016-2026 (USD Billion)
7.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Parenteral
7.4.3. Others
Chapter 8. Global Cyclooxygenase2 inhibitor Market, by End-Users
8.1. Market Snapshot
8.2. Global Cyclooxygenase2 inhibitor Market by End-Users, Performance - Potential Analysis
8.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by End-Users 2016-2026 (USD Billion)
8.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Specialty Clinics
8.4.3. Others
Chapter 9. Global Cyclooxygenase2 inhibitor Market, Regional Analysis
9.1. Global Cyclooxygenase2 inhibitor Market, Regional Market Snapshot
9.2. North America Global Cyclooxygenase2 inhibitor Market
9.2.1. U.S. Global Cyclooxygenase2 inhibitor Market
9.2.1.1. Indication breakdown estimates & forecasts, 2016-2026
9.2.1.2. Type breakdown estimates & forecasts, 2016-2026
9.2.1.3. Route of Administration breakdown estimates & forecasts, 2016-2026
9.2.1.4. End-Users Channel breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Global Cyclooxygenase2 inhibitor Market
9.3. Europe Global Cyclooxygenase2 inhibitor Market Snapshot
9.3.1. U.K. Global Cyclooxygenase2 inhibitor Market
9.3.2. Germany Global Cyclooxygenase2 inhibitor Market
9.3.3. Rest of Europe Global Cyclooxygenase2 inhibitor Market
9.4. Asia-Pacific Global Cyclooxygenase2 inhibitor Market Snapshot
9.4.1. China Global Cyclooxygenase2 inhibitor Market
9.4.2. India Global Cyclooxygenase2 inhibitor Market
9.4.3. Japan Global Cyclooxygenase2 inhibitor Market
9.4.4. Rest of Asia Pacific Global Cyclooxygenase2 inhibitor Market
9.5. Latin America Global Cyclooxygenase2 inhibitor Market Snapshot
9.5.1. Brazil Global Cyclooxygenase2 inhibitor Market
9.5.2. Mexico Global Cyclooxygenase2 inhibitor Market
9.6. Rest of The World Global Cyclooxygenase2 inhibitor Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Indication Summary
10.2.1.5. Recent Developments
10.2.2. Bayer AG
10.2.3. Novartis AG
10.2.4. Sabinsa
10.2.5. Cadila Pharmaceuticals
10.2.6. Mylan N.V.
10.2.7. Teva Pharmaceutical Industries Ltd.
10.2.8. Alembic Pharmaceuticals Limited
10.2.9. Aurobindo Pharma
10.2.10. Cipla Inc.
10.2.11. Torrent Pharmaceuticals Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Pfizer Inc.
Bayer AG
Novartis AG
Sabinsa
Cadila Pharmaceuticals
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Alembic Pharmaceuticals Limited
Aurobindo Pharma
Cipla Inc.
Torrent Pharmaceuticals Ltd.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports